In the 1950s Salk and Sabin developed separate vaccines—one from killed virus and the other from live virus—to combat the dreaded disease polio. Jonas Salk became a national hero when he allayed the fear of polio with his vaccine, approved in 1955.

Which type of vaccine is Salk vaccine?

polio vaccine inactivated poliovirus vaccine (IPV) or Salk vaccine, was developed in the early 1950s by American physician Jonas Salk. This vaccine contains killed virus and is given by injection. The large-scale use of IPV began in February 1954, when it was administered to American schoolchildren.

What were the side effects of the Salk vaccine?

The main serious side effect associated with the polio vaccine is an allergic reaction, though this is very rare. The Centers for Disease Control and Prevention estimates that about 1 in 1 million doses causes an allergic reaction.

What is the Sabin treatment?

oral poliovirus vaccine (OPV), or Sabin vaccine, named for its inventor, Albert Sabin. IPV, based on killed, or inactivated, poliovirus serotypes 1, 2, and 3, was the first vaccine to break the scourge of polio epidemics in the 1950s. It is administered by injection and circulates through the bloodstream, where…

How long did Jonas Salk work on the polio vaccine?

Salk worked incessantly for two-and-a-half years. Salk’s inactivated polio vaccine came into use in 1955.

How long did the Salk vaccine take to develop?

The foundation allowed itself to go into debt to finance the final research required to develop the Salk vaccine. Salk worked incessantly for two-and-a-half years. Salk’s inactivated polio vaccine came into use in 1955.

How long did it take Jonas Salk to develop the polio vaccine?

When did they stop giving the polio vaccine?

OPV was recommended for use in the United States for almost 40 years, from 1963 until 2000. The results have been miraculous: Polio was eliminated from the United States in 1979 and from the Western Hemisphere in 1991. Since 2000, only IPV is recommended to prevent polio in the United States.

Is Salk a live vaccine?

In 1955, Salk2 developed the inactivated poliovirus vaccine; thus began widespread immunisation. This was followed in 1960 by a live, attenuated oral vaccine developed by Sabin.